Compare Davita Inc (DVA) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Skyworks Solutions Inc — how do they compare? Davita Inc trades at $179.17 (market cap $11.58B), while Skyworks Solutions Inc trades at $69.77 (market cap $10.48B). The key difference: Davita Inc and Skyworks Solutions Inc are close in size by market cap, and Skyworks Solutions Inc pays a 4.13% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | SWKS | |
|---|---|---|
Market Cap | $11.58B | $10.48B |
Sector | Health | Technology |
52-Week High | $240.96 | $83.40 |
52-Week Low | $103.87 | $52.50 |
Enterprise Value | $24.30B | $10.36B |
Dividend Yield | — | 4.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $179.17, showing modest daily gains of 0.47% amid bearish technical signals. The stock demonstrates strong fundamental performance with consistent earnings beats (Q2 2026 EPS of $4.02 vs. $3.88 expected) and attractive valuation metrics including P/E of 15.38 and P/S of 0.91. Recent news highlights volume growth momentum but concerns about narrowing margins and reimbursement pressures. Analyst consensus remains positive with a $232.25 price target representing 30% upside potential from current levels.
The outlook remains cautiously optimistic given DVA's strong earnings track record and institutional support, though investors face risks from reimbursement pressure, high debt levels (debt-to-asset ratio of 65.55% in 2025), and mixed technical indicators. The stock's current valuation presents opportunity if margin pressures ease and volume growth continues as projected through 2026.
Skyworks Solutions (SWKS) trades at $69.76, up 2.09% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $66.00. Recent Q3 2026 earnings beat expectations with EPS of $1.08 versus $1.03 expected, driven by broad markets growth including AI data centers. The company is progressing toward a combination with Qorvo, with regulatory approvals underway and a leadership team announced for the merged entity.
The stock offers exposure to semiconductor demand in automotive and AI, but faces risks from revenue contraction, margin pressure, and integration challenges with Qorvo. Near-term support lies at $68, with resistance at $71. Institutional buying and a 58% buy rating from analysts provide tailwinds, though high RSI levels suggest caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
